Noortje van Maarseveen

Author

University Medical Center Utrecht

Also Known As

E E Mattsson, M. P. A. van Meer, N van Maarseveen, N. van Maarseveen, Noortje van Maarseveen, Remco Dijkman

Publications

450

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht National Institute for Public Health and the Environment Synergetics (Belgium)Leiden University Medical Center

About

Noortje van Maarseveen is an author at University Medical Center Utrecht specializing in medicine, infection control, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	56
2	Epidemiology	2	2	44
3	Immunology	2	2	44
4	Health Sciences	1	1	12
5	Public Health	1	1	27

Noortje van Maarseveen

Publications

402

Citations

H-Index

Page 1

	Year	Citations
Rapid and Sensitive Routine Detection of All Members of the Genus <i>Enterovirus</i> in Different Clinical Specimens by Real-Time PCR Monique Nijhuis, Noortje van Maarseveen, Rob Schuurman, Journal of Clinical Microbiology	2002	160
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, Nature Communications	2022	139
Laboratory-based surveillance in the molecular era: the TYPENED model, a joint data-sharing platform for clinical and public health laboratories Hubert G.M. Niesters, John W. A. Rossen, Harrie van der Avoort, Eurosurveillance	2013	37
Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared to Delta variant in the Netherlands, 13 – 26 December 2021 Jantien A. Backer, Dirk Eggink, Stijn P. Andeweg, Growth AdvantageImmune EvasionShorter Serial IntervalsPathogenesisImmunology	2022	27
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, ImmunodeficienciesImmunologyOmicron Ba.1Covid-19Booster Vaccination	2022	17
A multi-centre prospective evaluation of the Check-Direct ESBL Screen for BD MAX as a rapid molecular screening method for extended-spectrum beta-lactamase-producing Enterobacteriaceae rectal carriage Tobias Engel, Brenda Slotboom, Noortje van Maarseveen, Journal of Hospital Infection Multi-centre Prospective EvaluationAntimicrobial SusceptibilityHealth SciencesPathogen DetectionAntimicrobial Resistance Gene	2017	12
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022 Stijn P. Andeweg, Brechje de Gier, Harry Vennema, Eurosurveillance	2023	10

Page 1